DEPUY IRELAND

Manufacturer adverse-event records for DEPUY IRELAND come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2009–2026 · thin-book · quiet Death-code · injury-heavy

Death-code intensity

DEPUY IRELAND is quieter on Death-coded events

Death-coded event_type rows are 0 of 4,407 (0.00% · quiet tercile among 443 manufacturers). Absolute volume is thin-book.

What the Death-code reading shows for DEPUY IRELAND

The standout signal for DEPUY IRELAND is Death-code intensity: 0.00% of 4,407 reports (quiet tercile), while absolute volume is thin-book.

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Injury at 2,358 (53.5% of event_type total). Peak single-year volume reaches 1,359 reports across 16 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,407
Total Reports
0
Event-type Death
2,358
Injury Reports
20
Device Types

Event Types

Injury 2,358 (53.5%)
Malfunction 2,049 (46.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 2,311 (52.6%)
2,030 (46.2%)
Other 45 (1.0%)
R 3 (0.1%)
D 1 (0.0%)
Hospitalization 1 (0.0%)

Yearly Trend

09
2009: 4
10
2010: 5
11
2011: 457
12
2012: 1,359
13
2013: 73
14
2014: 90
15
2015: 30
16
2016: 33
17
2017: 60
19
2019: 1
21
2021: 4
22
2022: 169
23
2023: 282
24
2024: 724
25
2025: 1,036
26
2026: 80